Lv21
138 积分 2024-01-05 加入
[(177)Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
2天前
已完结
Management of Acute Hypocalcemia
3个月前
已完结
Risk of renal failure in cancer patients with bone metastasis treated with renally adjusted zoledronic acid
4个月前
已完结
Time Course of Calcium Concentrations and Risk Factors for Hypocalcemia in Patients Receiving Denosumab for the Treatment of Bone Metastases From Cancer
4个月前
已完结
Feasibility of extended dosing intervals of denosumab
4个月前
已完结
Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review
4个月前
已完结
Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers
4个月前
已完结
Prostate cancer
7个月前
已关闭
Prostate Cancer
7个月前
已完结
PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy
9个月前
已完结
皖公网安备34019202002308
